Sangamo Therapeutics, Inc financial data

Symbol
SGMO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
501 Canal Blvd., Richmond, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
SANGAMO BIOSCIENCES INC (to 1/6/2017)
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 200 % -32.5%
Debt-to-equity 104 % +62.3%
Return On Equity -40.4 % +10.5%
Return On Assets -165 % -298%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 208M shares +17.6%
Common Stock, Shares, Outstanding 178M shares +6.8%
Entity Public Float 229M USD -63.8%
Common Stock, Value, Issued 2.08M USD +17.6%
Weighted Average Number of Shares Outstanding, Basic 204M shares +17%
Weighted Average Number of Shares Outstanding, Diluted 204M shares +17%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 12.3M USD -94.4%
Research and Development Expense 168M USD -34.8%
General and Administrative Expense 50.8M USD -23.9%
Operating Income (Loss) -257M USD -19.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -249M USD -21.6%
Income Tax Expense (Benefit) 1.17M USD
Net Income (Loss) Attributable to Parent -250M USD -25.8%
Earnings Per Share, Basic -1.4 USD/shares -17.6%
Earnings Per Share, Diluted -1.39 USD/shares -15.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 27.8M USD -58.4%
Cash, Cash Equivalents, and Short-term Investments 81M USD -73.7%
Accounts Receivable, after Allowance for Credit Loss, Current 581K USD -78.6%
Assets, Current 40.1M USD -74.9%
Property, Plant and Equipment, Net 20.6M USD -66%
Operating Lease, Right-of-Use Asset 18.7M USD -60.1%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Goodwill 0 USD -100%
Other Assets, Noncurrent 16.6M USD -2.33%
Assets 93M USD -71.4%
Accounts Payable, Current 17.6M USD +18.6%
Accrued Liabilities, Current 15.8M USD -16.9%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 39M USD -27.5%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 29.1M USD -20%
Other Liabilities, Noncurrent 1.22M USD -3.55%
Liabilities 69.3M USD -24.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5.88M USD +0.89%
Retained Earnings (Accumulated Deficit) -1.49B USD -20.1%
Stockholders' Equity Attributable to Parent 23.7M USD -89.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 82.9M USD -71.9%
Liabilities and Equity 93M USD -71.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -48.7M USD +26.6%
Net Cash Provided by (Used in) Financing Activities 22.1M USD +176%
Net Cash Provided by (Used in) Investing Activities 35.8M USD +0.31%
Common Stock, Shares Authorized 960M shares +50%
Common Stock, Shares, Issued 178M shares +6.8%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.63M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 27.8M USD -59.3%
Deferred Tax Assets, Valuation Allowance 351M USD +16.4%
Deferred Tax Assets, Gross 357M USD +9.97%
Operating Lease, Liability 38.1M USD -11.6%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -250M USD -30.5%
Lessee, Operating Lease, Liability, to be Paid 45.2M USD -13.9%
Property, Plant and Equipment, Gross 77.9M USD -22.1%
Operating Lease, Liability, Current 4.59M USD +11.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.56M USD +3.29%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.83M USD -0.07%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6.88M USD -25%
Lessee, Operating Lease, Liability, to be Paid, Year Three 7.54M USD -0.19%
Deferred Tax Assets, Operating Loss Carryforwards 197M USD +13%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 18.3M USD +0.78%
Lessee, Operating Lease, Liability, to be Paid, Year Four 7.49M USD -0.64%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 1.41M USD -59.7%
Deferred Tax Assets, Net of Valuation Allowance 5.76M USD -74.9%
Share-based Payment Arrangement, Expense 18.1M USD -41.9%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%